Xiaowei Qi
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 30
- Oncology 55
- HER2/EGFR in Cancer Research 13
- Colorectal Cancer Treatments and Studies 11
- Cancer Immunotherapy and Biomarkers 10
- Cancer Cells and Metastasis 7
- Co-authors
- Jun Jiang (39 shared papers)Wei Sun (8 shared papers)Yuan Yin (8 shared papers)Hongwei Gao (4 shared papers)Yi Zhang (23 shared papers)Junlan Liu (4 shared papers)Long Yuan (12 shared papers)Yong Mao (15 shared papers)
- Journals
- Frontiers in Oncology (8 papers)Journal of Nanobiotechnology (4 papers)Scientific Reports (3 papers)The Oncologist (3 papers)Breast Cancer Research and Treatment (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaowei Qi
181 papers receiving 4.3k citations
Xiaowei Qi's Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 1.1k
- Oncology 716
- Drug Discovery 9
- Sensory Systems 91
- Molecular Biology 1.1k
Countries citing papers authored by Xiaowei Qi
This map shows the geographic impact of Xiaowei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Qi more than expected).
Fields of papers citing papers by Xiaowei Qi
This network shows the impact of papers produced by Xiaowei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Qi. The network helps show where Xiaowei Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 322 | |
| 2 | 2014 | 169 | |
| 3 | Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. | 2019 | 119 |
| 4 | 2022 | 116 | |
| 5 | 2018 | 114 | |
| 6 | 2018 | 114 | |
| 7 | Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis Hit paper breakdown → | 2024 | 112 |
| 8 | 2017 | 101 | |
| 9 | 2014 | 97 | |
| 10 | 2015 | 96 | |
| 11 | 2014 | 92 | |
| 12 | 2016 | 82 | |
| 13 | 2018 | 81 | |
| 14 | 2012 | 71 | |
| 15 | 2014 | 61 | |
| 16 | 2021 | 61 | |
| 17 | Multifaceted regulation and functions of replication factor C family in human cancers. | 2018 | 58 |
| 18 | 2012 | 57 | |
| 19 | 2012 | 55 | |
| 20 | 2011 | 54 |
About Xiaowei Qi
Xiaowei Qi is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Biomaterials, having authored 184 papers that have together received 4.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Cells and Metastasis (7 papers), Electrochemical sensors and biosensors (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (716 citations), Drug Discovery (9 citations), Sensory Systems (91 citations) and Molecular Biology (1.1k citations). Xiaowei Qi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jun Jiang, Wei Sun, Yuan Yin, Hongwei Gao, Yi Zhang, Junlan Liu, Long Yuan, Yong Mao, Dong Hua and Linfang Jin. Their work appears in journals such as Frontiers in Oncology, Journal of Nanobiotechnology, Scientific Reports, The Oncologist and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.